Parkinson’s disease (PD) is characterized by a loss of dopaminergic projections to the striatum, leading to both motor and cognitive impairments. The cognitive impairments are relatively selective and include deficits in incremental learning from trial-by-trial feedback, while other forms of learning, such as hippocampal-dependent episodic memory, remain intact. Interestingly, it has been suggested that the striatum and the hippocampus compete during learning, leading to the intriguing prediction that the striatal disruption in PD could lead to enhanced performance on tasks that depend on the hippocampus. We tested this prediction by simultaneously assessing incremental learning and episodic memory for trial-unique feedback events, within a single task, in patients with PD. Further, in order to modulate the engagement of the striatum versus the hippocampus, we manipulated the timing of feedback during learning, building on prior results showing that delaying feedback by a few seconds shifts learning to depend on the hippocampus instead of the striatum. We found that Parkinson’s patients were impaired at learning from immediate feedback, but had enhanced episodic memory for those immediate feedback events. Thus, our results provide evidence for concurrent impaired and enhanced learning and memory functions within the same group of patients from a single task.

Keywords:
Delayed feedback, Dopaminergic medication, Episodic memory, Feedback-based learning, Hippocampus, Incremental learning, Memory function, Striatum
1.
Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raisman R, Ruberg M: Biochemistry of Parkinson’s disease 28 years later: a critical review. Mov Disord 1989;4(suppl 1):S126–S144.
2.
Hornykiewicz O: Ageing and neurotoxins as causative factors in idiopathic Parkinson’s disease – a critical analysis of the neurochemical evidence. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:319–328.
3.
White NM, McDonald RJ: Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 2002;77:125–184.
4.
Knowlton BJ, Mangels JA, Squire LR: A neostriatal habit learning system in humans. Science 1996;273:1399–1402.
5.
Saint-Cyr JA, Taylor AE, Lang AE: Procedural learning and neostriatal dysfunction in man. Brain 1988;111(Pt 4):941–959.
6.
Saint-Cyr JA, Taylor AE, Nicholson K: Behavior and the basal ganglia. Adv Neurol 1995;65:1–28.
7.
Salmon DP, Butters N: Neurobiology of skill and habit learning. Curr Opin Neurobiol 1995;5:184–190.
8.
Frank MJ: Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 2005;17:51–72.
9.
Cools R: Dopaminergic modulation of cognitive function – implications for l-DOPA treatment in Parkinson’s disease. Neurosci Biobehav Rev 2006;30:1–23.
10.
Moustafa AA, Gluck MA: A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients. J Cogn Neurosci 2011;23:151–167.
11.
Schultz W: Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 1997;7:191–197.
12.
Faure A, Haberland U, Conde F, El Massioui N: Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci 2005;25:2771–2780.
13.
Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD: Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006;442:1042–1045.
14.
Shohamy D, Myers CE, Grossman S, Sage J, Gluck MA, Poldrack RA: Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. Brain 2004;127(Pt 4):851–859.
15.
Frank MJ, Seeberger LC, O’Reilly RC: By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004;306:1940–1943.
16.
Myers CE, Shohamy D, Gluck MA, Grossman S, Kluger A, Ferris S, Golomb J, Schnirman G, Schwartz R: Dissociating hippocampal versus basal ganglia contributions to learning and transfer. J Cogn Neurosci 2003;15:185–193.
17.
Schonberg T, O’Doherty JP, Joel D, Inzelberg R, Segev Y, Daw ND: Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson’s disease patients: evidence from a model-based fMRI study. Neuroimage 2010;49:772–781.
18.
Foerde K, Shohamy D: Feedback timing modulates brain systems for learning in humans. J Neurosci 2011;31:13157–13167.
19.
Jahanshahi M, Wilkinson L, Gahir H, Dharmarinda A, Lagnado DA: Medication impairs probabilistic classification learning in Parkinson’s disease. Neuropsychologia 2010;48:1096–1103.
20.
Frank MJ, Samanta J, Moustafa AA, Sherman SJ: Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309–1312.
21.
Foerde K, Shohamy D: The role of the basal ganglia in learning and memory: insight from Parkinson’s disease. Neurobiol Learn Mem 2011;96:624–636.
22.
Ashby FG, Maddox WT: Human category learning. Annu Rev Psychol 2005;56:149–178.
23.
Filoteo JV, Maddox WT, Salmon DP, Song DD: Information-integration category learning in patients with striatal dysfunction. Neuropsychology 2005;19:212–222.
24.
Cools R, Barker RA, Sahakian BJ, Robbins TW: Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136–1143.
25.
Cools R, Altamirano L, D’Esposito M: Reversal learning in Parkinson’s disease depends on medication status and outcome valence. Neuropsychologia 2006;44:1663–1673.
26.
Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW: l-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson’s disease. Neuropsychopharmacology 2007;32:180–189.
27.
Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM: Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 2002;125(Pt 3):584–594.
28.
Shohamy D, Myers CE, Geghman KD, Sage J, Gluck MA: L-dopa impairs learning, but spares generalization, in Parkinson’s disease. Neuropsychologia 2006;44:774–784.
29.
Seo M, Beigi M, Jahanshahi M, Averbeck BB: Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson’s disease. Front Syst Neurosci 2010;4:36.
30.
Dayan P, Balleine BW: Reward, motivation, and reinforcement learning. Neuron 2002;36:285–298.
31.
Daw ND, Doya K: The computational neurobiology of learning and reward. Curr Opin Neurobiol 2006;16:199–204.
32.
Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N, Dibo G, Takats A, Bereczki D, Gluck MA: Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain 2009;132(Pt 9):2385–2395.
33.
Shiner T, Seymour B, Wunderlich K, Hill C, Bhatia KP, Dayan P, Dolan RJ: Dopamine and performance in a reinforcement learning task: evidence from Parkinson’s disease. Brain 2012;135(Pt 6):1871–1883.
34.
Smittenaar P, Chase HW, Aarts E, Nusselein B, Bloem BR, Cools R: Decomposing effects of dopaminergic medication in Parkinson’s disease on probabilistic action selection – learning or performance? Eur J Neurosci 2012;35:1144–1151.
35.
Foerde K, Knowlton BJ, Poldrack RA: Modulation of competing memory systems by distraction. Proc Natl Acad Sci USA 2006;103:11778–11783.
36.
Gabrieli JD: Cognitive neuroscience of human memory. Annu Rev Psychol 1998;49:87–115.
37.
Squire LR, Zola SM: Structure and function of declarative and nondeclarative memory systems. Proc Natl Acad Sci USA 1996;93:13515–13522.
38.
Knowlton BJ, Squire LR, Gluck MA: Probabilistic classification learning in amnesia. Learn Mem 1994;1:106–120.
39.
Reber PJ, Knowlton BJ, Squire LR: Dissociable properties of memory systems: differences in the flexibility of declarative and nondeclarative knowledge. Behav Neurosci 1996;110:861–871.
40.
Poldrack RA, Packard MG: Competition among multiple memory systems: converging evidence from animal and human brain studies. Neuropsychologia 2003;41:245–251.
41.
Frank MJ, O’Reilly RC, Curran T: When memory fails, intuition reigns: midazolam enhances implicit inference in humans. Psychol Sci 2006;17:700–707.
42.
Poldrack RA, Clark J, Pare-Blagoev EJ, Shohamy D, Moyano JC, Myers C, Gluck MA: Interactive memory systems in the human brain. Nature 2001;414:546–550.
43.
Voermans NC, Petersson KM, Daudey L, Weber B, Van Spaendonck KP, Kremer HP, Fernandez G: Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 2004;43:427–435.
44.
Lieberman MD, Chang GY, Chiao J, Bookheimer SY, Knowlton BJ: An event-related fMRI study of artificial grammar learning in a balanced chunk strength design. J Cogn Neurosci 2004;16:427–438.
45.
Moody TD, Bookheimer SY, Vanek Z, Knowlton BJ: An implicit learning task activates medial temporal lobe in patients with Parkinson’s disease. Behav Neurosci 2004;118:438–442.
46.
Packard MG, Hirsh R, White NM: Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems. J Neurosci 1989;9:1465–1472.
47.
Packard MG, Knowlton BJ: Learning and memory functions of the basal ganglia. Annu Rev Neurosci 2002;25:563–593.
48.
Packard MG, McGaugh JL: Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: further evidence for multiple memory systems. Behav Neurosci 1992;106:439–446.
49.
Packard MG, McGaugh JL: Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol Learn Mem 1996;65:65–72.
50.
Packard MG, Teather LA: Double dissociation of hippocampal and dorsal-striatal memory systems by posttraining intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav Neurosci 1997;111:543–551.
51.
Packard MG, White NM: Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 1991;105:295–306.
52.
McDonald RJ, White NM: A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav Neurosci 1993;107:3–22.
53.
McDonald RJ, White NM: Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav Neural Biol 1994;61:260–270.
54.
Schroeder JP, Wingard JC, Packard MG: Post-training reversible inactivation of hippocampus reveals interference between memory systems. Hippocampus 2002;12:280–284.
55.
Hopkins RO, Myers CE, Shohamy D, Grossman S, Gluck M: Impaired probabilistic category learning in hypoxic subjects with hippocampal damage. Neuropsychologia 2004;42:524–535.
56.
Gluck MA, Shohamy D, Myers C: How do people solve the ‘weather prediction’ task? Individual variability in strategies for probabilistic category learning. Learn Mem 2002;9:408–418.
57.
Fiorillo CD, Newsome WT, Schultz W: The temporal precision of reward prediction in dopamine neurons. Nat Neurosci 2008;11:966–973.
58.
Kobayashi S, Schultz W: Influence of reward delays on responses of dopamine neurons. J Neurosci 2008;28:7837–7846.
59.
Davachi L: Item, context and relational episodic encoding in humans. Curr Opin Neurobiol 2006;16:693–700.
60.
Wallenstein GV, Eichenbaum H, Hasselmo ME: The hippocampus as an associator of discontiguous events. Trends Neurosci 1998;21:317–323.
61.
Cohen NJ, Eichenbaum H: Memory, Amnesia, and the Hippocampal System. Cambridge, MIT Press, 1993.
62.
Shohamy D, Wagner AD: Integrating memories in the human brain: hippocampal-midbrain encoding of overlapping events. Neuron 2008;60:378–389.
63.
Cavaco S, Anderson SW, Allen JS, Castro-Caldas A, Damasio H: The scope of preserved procedural memory in amnesia. Brain 2004;127(Pt 8):1853–1867.
64.
Klimkowicz-Mrowiec A, Slowik A, Krzywoszanski L, Herzog-Krzywoszanska R, Szczudlik A: Severity of explicit memory impairment due to Alzheimer’s disease improves effectiveness of implicit learning. J Neurol 2008;255:502–509.
65.
Davidson PS, Anaki D, Saint-Cyr JA, Chow TW, Moscovitch M: Exploring the recognition memory deficit in Parkinson’s disease: estimates of recollection versus familiarity. Brain 2006;129(Pt 7):1768–1779.
66.
Whittington CJ, Podd J, Kan MM: Recognition memory impairment in Parkinson’s disease: power and meta-analyses. Neuropsychology 2000;14:233–246.
67.
Whittington CJ, Podd J, Stewart-Williams S: Memory deficits in Parkinson’s disease. J Clin Exp Neuropsychol 2006;28:738–754.
68.
Cohn M, Moscovitch M, Davidson PS: Double dissociation between familiarity and recollection in Parkinson’s disease as a function of encoding tasks. Neuropsychologia 2010;48:4142–4147.
69.
Bronnick K, Alves G, Aarsland D, Tysnes OB, Larsen JP: Verbal memory in drug-naive, newly diagnosed Parkinson’s disease. The retrieval deficit hypothesis revisited. Neuropsychology 2011;25:114–124.
70.
Hay JF, Moscovitch M, Levine B: Dissociating habit and recollection: evidence from Parkinson’s disease, amnesia and focal lesion patients. Neuropsychologia 2002;40:1324–1334.
71.
Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO: Impaired cognitive performance in Parkinson’s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 2009;15:88–93.
72.
Kenny ER, Burton EJ, O’Brien JT: A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies. A comparison with Alzheimer’s disease and Parkinson’s disease with and without dementia. Dement Geriatr Cogn Disord 2008;26:218–225.
73.
Rutledge RB, Lazzaro SC, Lau B, Myers CE, Gluck MA, Glimcher PW: Dopaminergic drugs modulate learning rates and perseveration in Parkinson’s patients in a dynamic foraging task. J Neurosci 2009;29:15104–15114.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.